Table 3.
Indications for stenting and tumor location respectively (n, %)
| Location of obstruction | Indications |
|---|---|
| BTS (277/434, 63.8%) | |
| Ascending colon | 5, 1.8% |
| Hepatic flexure | 17, 6.1% |
| Transverse colon | 6, 2.2% |
| Splenic flexure | 22, 7.9% |
| Descending colon | 44, 15.9% |
| Descending sigmoid colon | 28, 10.1% |
| Sigmoid colon | 84, 30.3% |
| Recto-sigmoid colon | 31, 11.2% |
| Rectal (1NEC) | 40, 14.4% |
| Palliative stents (124/434, 28.6%) | |
| Ascending colon | 1, 0.8% |
| Hepatic flexure | 10, 8.1% |
| Transverse colon | 7, 5.6% |
| Splenic flexure | 6, 4.8% |
| Descending colon | 18, 14.5% |
| Descending sigmoid colon | 5, 4.0% |
| Sigmoid colon | 37, 29.8% |
| Recto-sigmoid | 17, 13.7% |
| Rectal | 23, 18.5% |
| Others (33/434, 7.6%) | |
| Recurrent tumor | 10, 30.3% |
| Sigmoid colon | 2 |
| Rectal | 8 |
| Benign diseases | 10, 30.3% |
| SLE | 1 |
| Anastomotic stenosis | 7 |
| Inflammatory stenosis | 1 |
| Foreign-body granuloma | 1 |
| Extra-luminal compression | 13, 39.4% |
| Transverse colon | 1 |
| Splenic flexure | 3 |
| Descending colon | 1 |
| Descending sigmoid colon | 1 |
| Sigmoid colon | 1 |
| Rectal | 6 |